Zinc improves Denosumab and eldecalcitol efficacy for bone mineral density in patients with hypozincemia

ConclusionHypozincemia may reduce the efficacy of DMAb and eldecalcitol in increasing BMD and fracture prevention.
Source: Journal of Bone and Mineral Metabolism - Category: Orthopaedics Source Type: research